2 research outputs found
Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2āPyridyl-1,2,3-triazole āClickā Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA)
A series of trisĀ(homoleptic) rutheniumĀ(II)
complexes of 2-(1-<b>R</b>-1<i>H</i>-1,2,3-triazol-4-yl)Āpyridine
āclickā
ligands (<b>R-pytri</b>) with various aliphatic (R = butyl,
hexyl, octyl, dodecyl, and hexdecyl) and aromatic (R = phenyl and
benzyl) substituents was synthesized in good yields (52%ā66%).
The [RuĀ(<b>R-pytri</b>)<sub>3</sub>]<sup>2+</sup>(X<sup>ā</sup>)<sub>2</sub> complexes (where X<sup>ā</sup> = PF<sub>6</sub><sup>ā</sup> or Cl<sup>ā</sup>) were characterized
by elemental analysis, high-resolution electrospray ionization mass
spectrometry (HR-ESI-MS), <sup>1</sup>H and <sup>13</sup>C nuclear
magnetic resonance (NMR) and infrared (IR) spectroscopies, and the
molecular structures of six of the compounds confirmed by X-ray crystallography. <sup>1</sup>H NMR analysis showed that the as-synthesized materials were
a statistical mixture of the <i>mer</i>- and <i>fac</i>-[RuĀ(<b>R-pytri</b>)<sub>3</sub>]<sup>2+</sup> complexes. These
diastereomers were separated using column chromatography. The electronic
structures of the <i>mer</i>- and <i>fac</i>-[RuĀ(<b>R-pytri</b>)<sub>3</sub>]<sup>2+</sup> complexes were examined
using ultravioletāvisible (UV-Vis) spectroscopy and cyclic
and differential pulse voltammetry. The family of <b>R-pytri</b> ligands and the corresponding <i>mer</i>- and <i>fac</i>-[RuĀ(<b>R-pytri</b>)<sub>3</sub>]<sup>2+</sup> complexes
were tested for antimicrobial activity <i>in vitro</i> against
both Staphylococcus aureus and Escherichia coli bacteria. Agar-based disk diffusion
assays indicated that two of the [RuĀ(<b>R-pytri</b>)<sub>3</sub>]Ā(X)<sub>2</sub> complexes (where X = PF<sub>6</sub><sup>ā</sup> and R = hexyl or octyl) displayed good antimicrobial activity against
Gram-positive S. aureus and no activity
against Gram-negative E. coli at the
concentrations tested. The most active [RuĀ(<b>R-pytri</b>)<sub>3</sub>]<sup>2+</sup> complexes ([RuĀ(<b>hexpytri</b>)<sub>3</sub>]<sup>2+</sup> and RuĀ(<b>octpytri</b>)<sub>3</sub>]<sup>2+</sup>) were converted to the water-soluble chloride salts and screened
for their activity against a wider range of pathogenic bacteria. As
with the preliminary screen, the complexes showed good activity against
a variety of Gram-positive strains (minimum inhibitory concentration
(MIC) = 1ā8 Ī¼g/mL) but were less effective against Gram-negative
bacteria (MIC = 16ā128 Ī¼g/mL). Most interestingly, in
some cases, the rutheniumĀ(II) āclickā complexes proved
more active (MIC = 4ā8 Ī¼g/mL) than the gentamicin control
(MIC = 16 Ī¼g/mL) against two strains of methicillin-resistant S. aureus (MRSA) (MR 4393 and MR 4549). Transmission
electron microscopy (TEM) experiments and propidium iodide assays
suggested that the main mode of action for the rutheniumĀ(II) <b>R-pytri</b> complexes was cell wall/cytoplasmic membrane disruption.
Cytotoxicity experiments on human dermal keratinocyte and Vero (African
green monkey kidney epithelial) cell lines suggested that the complexes
were only modestly cytotoxic at concentrations well above the MIC
values
[Re(CO)<sub>3</sub>]<sup>+</sup> Complexes of <i>exo</i>-Functionalized Tridentate āClickā Macrocycles: Synthesis, Stability, Photophysical Properties, Bioconjugation, and Antibacterial Activity
There is considerable interest in
the development of bifunctional ligand scaffolds for the group 7 metals
due to potential biological applications. Building on our recent work
in the development of āclickā ligands and macrocycles,
we show that a CuAAC āclickā approach can be exploited
for the synthesis of a small family of bioconjugated tridentate pyridyl-1,2,3-triazole
macrocycles. These bioconjugated tridentate macrocycles form stable
[ReĀ(CO)<sub>3</sub>]<sup>+</sup> complexes, and this could facilitate
the development of [MĀ(CO)<sub>3</sub>]<sup>+</sup> (M = Mn, Tc, Re)
targeted agents. The parent macrocycle, bioconjugates, and [ReĀ(CO)<sub>3</sub>]<sup>+</sup> complexes were characterized by elemental analysis
and HR-ESI-MS, <sup>1</sup>H and <sup>13</sup>C NMR, and IR spectroscopy,
and the molecular structures of the alcohol-functionalized macrocycle
and two of the ReĀ(I) complexes were confirmed by X-ray crystallography.
The electronic structure of the parent [ReĀ(CO)<sub>3</sub>]<sup>+</sup> macrocycle complex was examined using UVāvis, Raman, and
emission spectroscopy and density functional theory calculations.
The complex exhibited intense absorptions in the UV region which were
modeled using time-dependent density functional theory (TD-DFT). The
calculations suggest that the lower energy part of the absorption
band is MLCT in nature and additional higher energy ĻāĻ*
transitions are present. The complex was weakly emissive at room temperature
in methanol with a quantum yield of 5.1 Ć 10<sup>ā3</sup> and correspondingly short excited state lifetime (Ļ ā
20 ns). The family of macrocycles and the corresponding ReĀ(I) complexes
were tested for antimicrobial activity <i>in vitro</i> against
both Gram positive (Staphylococcus aureus) and Gram negative (Escherichia coli) microorganisms. Agar-based disk diffusion assays indicated that
two of the ReĀ(I) complexes displayed antimicrobial activity but the
minimum inhibitory concentrations (MIC) for these compounds proved
to be extremely modest (MIC > 256 Ī¼g/mL)